Provided by Tiger Trade Technology Pte. Ltd.

Urogen Pharma Ltd.

19.10
+1.075.93%
Post-market: 19.100.00000.00%19:31 EDT
Volume:817.19K
Turnover:15.41M
Market Cap:929.83M
PE:-5.99
High:19.55
Open:19.55
Low:18.25
Close:18.03
52wk High:30.00
52wk Low:3.42
Shares:48.68M
Float Shares:36.78M
Volume Ratio:1.56
T/O Rate:2.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1901
EPS(LYR):-3.1901
ROE:-1481.26%
ROA:-32.10%
PB:-8.82
PE(LYR):-5.99

Loading ...

May 01, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 10, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Feb 20, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Major Issues Report

Form 8-K - Current report
Sep 24, 2024

Major Issues Report

Form 8-K - Current report
Sep 13, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2024

Major Issues Report

Form 8-K - Current report